The eMurmur ID mobile solution is intended for use with a third party electronic stethoscope. Credit: StockSnap from Pixabay.

Canadian medical technology firm eMurmur has secured the US Food and Drug Administration (FDA) clearance for its artificial intelligence (AI) powered mobile solution to detect heart murmurs.

Dubbed eMurmur ID, the mobile solution is intended for use with a third party electronic stethoscope.

Go deeper with GlobalData

Data Insights

The gold standard of business intelligence.

Find out more

Related Company Profiles

View all

It leverages machine learning to detect and categorise pathologic and innocent heart murmurs, the absence of a heart murmur, as well as S1, S2 heart sounds.

In addition to AI-based analytics and a mobile app, eMurmur ID consists of a web portal. The solution is believed to have applications in primary and specialty care, and corporate health.

eMurmur co-founder and CEO Andreas Schriefl said: “Receiving FDA clearance marks a significant milestone in our company’s history, and I’m very excited to finally be able to take the eMurmur ID solution to market.

“eMurmur ID has the potential to disrupt the status-quo of heart murmur screening and significantly reduce costs to healthcare systems worldwide.”

“We believe that eMurmur ID has the potential to disrupt the status-quo of heart murmur screening and significantly reduce costs to healthcare systems worldwide.”

How well do you really know your competitors?

Access the most comprehensive Company Profiles on the market, powered by GlobalData. Save hours of research. Gain competitive edge.

Company Profile – free sample

Thank you!

Your download email will arrive shortly

Not ready to buy yet? Download a free sample

We are confident about the unique quality of our Company Profiles. However, we want you to make the most beneficial decision for your business, so we offer a free sample that you can download by submitting the below form

By GlobalData
Visit our Privacy Policy for more information about our services, how we may use, process and share your personal data, including information of your rights in respect of your personal data and how you can unsubscribe from future marketing communications. Our services are intended for corporate subscribers and you warrant that the email address submitted is your corporate email address.

Heart disease, considered as the primary cause of death worldwide, is responsible for 31% of total deaths per year. The disease is commonly screened by listening with a stethoscope, called heart auscultation, for abnormal heart sounds or murmurs.

However, heart auscultation is known to be subjective and is said to have a low accuracy rate of 20%-25% in primary care.

The new solution is said to offer better auscultation, with an accuracy rate of more than 85%.

The solution has been assessed in five clinical studies involving a total of more than 1,000 patients.

Data showed that the automated heart murmur detection technology was accurate, informative and easy to use, offering a screening tool for confirming clinical diagnoses.